| 1. |
2024
Sethy Bidyadhar,Yu Zih Yao,Narwanti Iin,Upadhyay Richa,Lai Mei Jung,Lee Sung Bau, Liou Jing Ping.
Design, synthesis, and biological evaluation of adenosine derivatives targeting DOT1L and HAT as anti-leukemia agents
. Bioorganic Chemistry
.2024
;(153):107771
|
|
| 2. |
2024
Bidyadhar Sethy,Richa Upadhyay,Iin Narwanti,Zih-Yao Yu,Sung-Bau Lee,Jing-Ping Liou.
Novel dual inhibitor targeting CDC25 and HDAC for treating triplenegative breast cancer
. Apoptosis
.2024
|
|
| 3. |
2024
Ting-Yu Chang,Yan Yan,Zih-Yao Yu,Moeez Rathore,Nian-Zhe Lee,Hui-Ju Tseng, Li-Hsin Cheng, Wei-Jan Huang, Wei Zhang, Ernest R. Chan, Yulan Qing, Ming-Lun Kang, Rui Wang, Kelvin K. Tsai, John J. Pink, William E. Harte, Stanton L. Gerson, Sung-Bau Lee.
Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical models
. Journal of Clinical Investigation
.2024
|
|
| 4. |
2023
Chu JC,Tseng HJ,Lee SB,Hsu KC,Hsin LW,Liang RH, Lin TE, Gao NC, Chen LC, Lu WH, Wang AH, Huang WJ..
Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities
. J Enzyme Inhib Med Chem
.2023
;(38):2212326
|
|
| 5. |
2023
Narwanti I,Yu ZY,Sethy B,Lai MJ,Lee HY,Olena P, Lee SB, Liou JP.
6-Regioisomeric 5,8-quinolinediones as potent CDC25 inhibitors against colorectal cancers
. Eur J Med Chem
.2023
;(258):115505
|
|
| 6. |
2023
Rana M,Thakur A,Kaur C,Pan CH,Lee SB,Liou JP, Nepali K..
Prudent tactics to sail the boat of PARP inhibitors as therapeutics for diverse malignancies
. Expert Opin Drug Discov
.2023
;(18):1169
|
|
| 7. |
2022
Ram Sharma,Esha Chatterjee,Jacob Mathew,Sachin Sharma,N. Vijayakameswara Rao,Chun-Hsu Pan, Sung-Bau Lee, Ashwani Dhingra, Ajmer S. Grewal, Jing Ping Liou, Santosh K. Guru, Kunal Nepali.
Accommodation of ring C expanded deoxyvasicinone in the HDAC inhibitory pharmacophore culminates into a tractable anti-lung cancer agent and pH-responsive nanocarrier.
. European Journal of Medicinal Chemistry
.2022
;(240):114602
|
|
| 8. |
2021
Arshdeep Singh,Ting-Yu Chang,Navdeep Kaur,Kai-Cheng Hsu,Yun Yen,Tony Eight Lin, Mei-Jung Lai, Sung-Bau Lee, Jing-Ping Liou.
CAP rigidification of MS-275 and Chidamide leads to Enhanced Antiproliferative effects mediated through HDAC1, 2 and Tubulin polymerization inhibition
. European Journal of Medicinal Chemistry
.2021
;(215):113169-113185
|
|
| 9. |
2021
Ting-Yu Chang,Kunal Nepali,Yi-Ying Chen,Yu-Chen S.H. Yang,Kai-Cheng Hsu,Yun Yen, Shiow-Lin Pan, Jing-Ping Liou, Sung-Bau Lee.
A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling
. Biomedicine & Pharmacotherapy
.2021
;(138):111485
|
|
| 10. |
2021
Sung-Bau Lee,Ting-Yu Chang,Nian-Zhe Lee,Zih-Yao Yu,Chi-Yuan Liu,Hsueh-Yun Lee.
Design, synthesis and biological evaluation of bisindole derivatives as anticancer agents against Tousled-like kinases
. European Journal of Medicinal Chemistry
.2021
;(227):113904-113920
|
|
| 11. |
2021
Hung-Yu Lin,Yong-Shiou Lin,Shou-Ping Shih,Sung-Bau Lee,Mohamed El-Shazly,Ken-Ming Chang, Yu-Chen S. H. Yang, Yi-Lun Lee, Mei-Chin Lu.
The Anti-Proliferative Activity of Secondary Metabolite from the Marine Streptomyces sp. against Prostate Cancer Cells
. Life (Basel)
.2021
|
|
| 12. |
2020
Nepali Kunal,Chang Ting Yu,Lai Mei Jung,Hsu Kai Cheng,Yen Yun,Lin Tony Eight,Lee Sung Bau,Liou Jing Ping.
Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors
. European Journal of Medicinal Chemistry
.2020
;(196)
|
|
| 13. |
2019
Chung-Che Tsai,Fang-Ting Kuo,Sung-Bau Lee,Yu-Ting Chang,Hua-Wen Fu.
Endocytosis-dependent lysosomal degradation of Src induced by protease-activated receptor 1
. FEBS Letters
.2019
;(593):504-517
|
|
| 14. |
2018
Sung-Bau Lee,Sandra Segura-Bayona,Marina Villamor-Payà,Giulia Saredi,Matthew A. M. Todd,Camille Stephan-Otto Attolini, Ting-Yu Chang, Travis H. Stracker, Anja Groth.
Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors
. Science Advances
.2018
;(4):eaat4985
|
|
| 15. |
2016
Feng Y,Vlassis A,Roques C,Lalonde ME,Gonzalez-Aguilera C,Lambert JP, Lee SB, Zhao X, Alabert C, Johansen JV, Paquet, E, Yang XJ, Gingras AC, Cote J & Groth A.
BRPF3-HBO1 regulates replication origin activation and histone H3K14 acetylation
. The EMBO Journal
.2016
;(35):176-192
|
|
| 16. |
2014
Alabert C,Bukowski-Wills JC,Lee SB,Kustatscher G,Nakamura K,de Lima Alves F, Menard P, Mejlvang J, Rappsilber J and Groth A.
Nascent chromatin capture proteomics determines chromatin dynamics during DNA replication and identifies unknown fork components
. Nature Cell Biology
.2014
;(16):281-293
|
|
| 17. |
2012
Hsu CH,Peng KL,Kang ML,Chen YR,Chu CS,Yang YC, Tsai CH, Jeng YM, Chen YT, Lin FM, Huang HD, Lu YY, Teng YC, Lin ST, Shen L, Lin RK, Lee SB.
TET1 suppresses cancer invasion via activating the tissue inhibitors of metalloproteinases
. Cell Reports
.2012
;(2):568-579
|
|
| 18. |
2012
Lee SB,Jasencakova Z,Groth A.
H3K56me1 Marks a Spot for PCNA
. Molecular Cell
.2012
;(46):1-2
|
|
| 19. |
2011
Ou DS,Lee SB,Chu CS,Chang LH,Chung BC,Juan LJ.
Transcriptional activation of endoplasmic reticulum chaperon GRP78 by HCMV IE1-72 protein
. Cell Research
.2011
;(21):642-653
|
|
| 20. |
2011
Lee SB,Lee CF,Ou DS,Dulal K,Chang LH,Ma CH, Huang CF, Zhu H, Lin YS and Juan LJ.
Host-viral effects of chromatin assembly factor 1 interaction with HCMV IE2.
. Cell Res
.2011
;(21):1230-1247
|
|
| 21. |
2010
Lee CF,Ou DS,Lee SB,Chang LH,Lin RK,Li YS, Upadhyay AK, Cheng X, Wang YC, Hsu HS, Hsiao M, Wu CW and Juan LJ.
hNaa10p/Human arrestdefective 1 contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing
. The Journal of Clinical Investigation
.2010
;(120):2920-2930
|
|
| 22. |
2009
Lee SB,Ou DS,Lee CF,Juan LJ.
Gene-specific transcriptional activation mediated by the p150 subunit of the chromatin assembly factor 1
. The Journal of Biological Chemistry
.2009
;(284):14040-14049
|
|